Lumason

Chemical Namesulfur hexafluoride lipid microsphere
Dosage FormInjection (intravenous; lipid-type A/ sulfur hexafluoride (25 mg/60.7 mg))
Drug ClassRadioactive diagnostic agent
SystemOther
CompanyBracco Diagnostics Inc.
Approval Year2014

Indication

  • Echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult and pediatric patients with suboptimal echocardiograms.
  • Ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients.
  • Ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux in pediatric patients.
Last updated on 6/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Lumason (sulfur hexafluoride lipid microsphere) Prescribing Information2014Bracco Diagnostics Inc., Monroe Township, NJ